The BioInnovation Institute (BII), an international non-profit foundation dedicated to incubating and accelerating world-class life science research, has unveiled the BII & Science Translational Medicine Prize for Innovations in Women’s Health and Gender Medicine. This new prize builds upon the success of the BII & Science Prize for Innovation, now in its third year. It aims to recognize and celebrate researchers globally who have developed pioneering advances with translational potential to impact women’s health and gender medicine.
The Translational Medicine Prize underscores BII’s commitment to supporting groundbreaking research that addresses crucial challenges in women’s health using innovative approaches. The initiative aligns with BII’s Women’s Health Initiative, which focuses on supporting startups and projects across various indication areas within women’s health.
Jens Nielsen, Chief Executive Officer of BII said: “We are proud to introduce this Prize alongside Science Journals, following the success of our Innovation Prize. Women’s Health remains a core focus for BII, and we continue to support early-stage start-ups and projects in the field, through programmes such as our collaboration with Ferring Pharmaceuticals. We hope this award, which will be announced in 2025, provides the well-deserved recognition of the researchers leading the way in this underserved area of research.”
Sudip Parikh, Chief Executive Officer and Executive Publisher of Science Journals added: “With approximately just 1% of healthcare research and innovation invested in female-specific conditions beyond oncology, it is a highly underserved area of healthcare. That is why we are pleased to be working alongside BII again to launch this award to recognize researchers who are developing innovative solutions to address female specific conditions.”
The prize will consider contributions within various areas of women’s health and gender medicine, including maternal health, chronic gynecological diseases, reproductive health, and sex- and gender-specific approaches to medical conditions. The winner will have their essay published in the Journal, Science Translational Medicine, and receive a cash reward of $25,000 to further their research.
Researchers who have made significant advances in translational research, clinical applications, drug development, diagnostic approaches, medical devices, or healthcare technologies in these fields are encouraged to apply. The Prize is awarded for outstanding research performed by the applicant
and as described in a 1,000-word essay. Application details and timelines will be announced soon.
